Literature DB >> 31085202

Distinct roles of myofibroblast-specific Smad2 and Smad3 signaling in repair and remodeling of the infarcted heart.

Shuaibo Huang1, Bijun Chen1, Ya Su1, Linda Alex1, Claudio Humeres1, Arti V Shinde1, Simon J Conway2, Nikolaos G Frangogiannis3.   

Abstract

TGF-βs regulate fibroblast responses, by activating Smad2 or Smad3 signaling, or via Smad-independent pathways. We have previously demonstrated that myofibroblast-specific Smad3 is critically implicated in repair of the infarcted heart. However, the role of fibroblast Smad2 in myocardial infarction remains unknown. This study investigates the role of myofibroblast-specific Smad2 signaling in myocardial infarction, and explores the mechanisms responsible for the distinct effects of Smad2 and Smad3. In a mouse model of non-reperfused myocardial infarction, Smad2 activation in infarct myofibroblasts peaked 7 days after coronary occlusion. In vitro, TGF-β1, -β2 and -β3, but not angiotensin 2 and bone morphogenetic proteins-2, -4 and -7, activated fibroblast Smad2. Myofibroblast-specific Smad2 and Smad3 knockout mice (FS2KO, FS3KO) and corresponding control littermates underwent non-reperfused infarction. In contrast to the increase in rupture rates and adverse remodeling in FS3KO mice, FS2KO animals had mortality comparable to Smad2 fl/fl controls, and exhibited a modest but transient improvement in dysfunction after 7 days of coronary occlusion. At the 28 day timepoint, FS2KO and Smad2 fl/fl mice had comparable adverse remodeling. Although both FS3KO and FS2KO animals had increased myofibroblast density in the infarct, only FS3KO mice exhibited impaired scar organization, associated with perturbed alignment of infarct myofibroblasts. In vitro, Smad3 but not Smad2 knockdown downmodulated fibroblast α2 and α5 integrin expression. Moreover, Smad3 knockdown reduced expression of the GTPase RhoA, whereas Smad2 knockdown markedly increased fibroblast RhoA levels. Smad3-dependent integrin expression may be important for fibroblast activation, whereas RhoA may transduce planar cell polarity pathway signals, essential for fibroblast alignment. Myofibroblast-specific Smad3, but not Smad2 is required for formation of aligned myofibroblast arrays in the infarct. The distinct in vivo effects of myofibroblast Smad2 and Smad3 may involve Smad3-dependent integrin synthesis, and contrasting effects of Smad2 and Smad3 on RhoA expression.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fibroblast; Myocardial infarction; Planar cell polarity; Smad; TGF-β

Mesh:

Substances:

Year:  2019        PMID: 31085202      PMCID: PMC6579679          DOI: 10.1016/j.yjmcc.2019.05.006

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  56 in total

Review 1.  A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.

Authors:  Kimberly A Brown; Jennifer A Pietenpol; Harold L Moses
Journal:  J Cell Biochem       Date:  2007-05-01       Impact factor: 4.429

2.  Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.

Authors:  E Piek; W J Ju; J Heyer; D Escalante-Alcalde; C L Stewart; M Weinstein; C Deng; R Kucherlapati; E P Bottinger; A B Roberts
Journal:  J Biol Chem       Date:  2001-03-21       Impact factor: 5.157

3.  Vangl2 acts via RhoA signaling to regulate polarized cell movements during development of the proximal outflow tract.

Authors:  Helen M Phillips; Jennifer N Murdoch; Bill Chaudhry; Andrew J Copp; Deborah J Henderson
Journal:  Circ Res       Date:  2005-01-06       Impact factor: 17.367

4.  Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb).

Authors:  N G Frangogiannis; L H Michael; M L Entman
Journal:  Cardiovasc Res       Date:  2000-10       Impact factor: 10.787

5.  Hierarchical model of gene regulation by transforming growth factor beta.

Authors:  Yaw-Ching Yang; Ester Piek; Jiri Zavadil; Dan Liang; Donglu Xie; Joerg Heyer; Paul Pavlidis; Raju Kucherlapati; Anita B Roberts; Erwin P Böttinger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-20       Impact factor: 11.205

6.  Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta ) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent.

Authors:  Chenghai Liu; Marianna D A Gaça; E Scott Swenson; Vincent F Vellucci; Michael Reiss; Rebecca G Wells
Journal:  J Biol Chem       Date:  2003-01-22       Impact factor: 5.157

7.  Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction.

Authors:  Oliver Dewald; Guofeng Ren; Georg D Duerr; Martin Zoerlein; Christina Klemm; Christine Gersch; Sophia Tincey; Lloyd H Michael; Mark L Entman; Nikolaos G Frangogiannis
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

8.  A novel E1A-like inhibitor of differentiation (EID) family member, EID-2, suppresses transforming growth factor (TGF)-beta signaling by blocking TGF-beta-induced formation of Smad3-Smad4 complexes.

Authors:  Ho-Jae Lee; Jin Kyung Lee; Satoshi Miyake; Seong-Jin Kim
Journal:  J Biol Chem       Date:  2003-11-11       Impact factor: 5.157

Review 9.  Smad regulation in TGF-beta signal transduction.

Authors:  A Moustakas; S Souchelnytskyi; C H Heldin
Journal:  J Cell Sci       Date:  2001-12       Impact factor: 5.285

10.  Induction of cell scattering by expression of beta1 integrins in beta1-deficient epithelial cells requires activation of members of the rho family of GTPases and downregulation of cadherin and catenin function.

Authors:  C Gimond; A van Der Flier; S van Delft; C Brakebusch; I Kuikman; J G Collard; R Fässler; A Sonnenberg
Journal:  J Cell Biol       Date:  1999-12-13       Impact factor: 10.539

View more
  26 in total

1.  Validation of diagnostic criteria and histopathological characterization of cardiac rupture in the mouse model of nonreperfused myocardial infarction.

Authors:  Anis Hanna; Arti V Shinde; Nikolaos G Frangogiannis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-09-04       Impact factor: 4.733

Review 2.  Human pluripotent stem cell-derived cardiac stromal cells and their applications in regenerative medicine.

Authors:  Martha E Floy; Taylor D Mateyka; Koji L Foreman; Sean P Palecek
Journal:  Stem Cell Res       Date:  2020-04-27       Impact factor: 2.020

Review 3.  Transforming growth factor-β in myocardial disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Nat Rev Cardiol       Date:  2022-01-04       Impact factor: 32.419

4.  The role of endogenous Smad7 in regulating macrophage phenotype following myocardial infarction.

Authors:  Jun Li; Ruoshui Li; Izabela Tuleta; Silvia C Hernandez; Claudio Humeres; Anis Hanna; Bijun Chen; Nikolaos G Frangogiannis
Journal:  FASEB J       Date:  2022-07       Impact factor: 5.834

Review 5.  Adding insult to injury - Inflammation at the heart of cardiac fibrosis.

Authors:  Sasha Smolgovsky; Udoka Ibeh; Tatiana Peña Tamayo; Pilar Alcaide
Journal:  Cell Signal       Date:  2020-11-06       Impact factor: 4.315

Review 6.  The role of Smad signaling cascades in cardiac fibrosis.

Authors:  Anis Hanna; Claudio Humeres; Nikolaos G Frangogiannis
Journal:  Cell Signal       Date:  2020-11-05       Impact factor: 4.315

Review 7.  Cardiac fibrosis.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

8.  Deletion of Smad3 protects against diabetic myocardiopathy in db/db mice.

Authors:  Li Dong; Jian-Chun Li; Zhong-Jing Hu; Xiao-Ru Huang; Li Wang; Hong-Lian Wang; Ronald C W Ma; Hui-Yao Lan; Si-Jin Yang
Journal:  J Cell Mol Med       Date:  2021-03-17       Impact factor: 5.310

9.  Prevention of Fibrosis and Pathological Cardiac Remodeling by Salinomycin.

Authors:  Ryan M Burke; Ronald A Dirkx; Pearl Quijada; Janet K Lighthouse; Amy Mohan; Meghann O'Brien; Wojciech Wojciechowski; Collynn F Woeller; Richard P Phipps; Jeffrey D Alexis; John M Ashton; Eric M Small
Journal:  Circ Res       Date:  2021-04-07       Impact factor: 23.213

Review 10.  Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches.

Authors:  Begoña López; Susana Ravassa; María U Moreno; Gorka San José; Javier Beaumont; Arantxa González; Javier Díez
Journal:  Nat Rev Cardiol       Date:  2021-02-10       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.